MRI analyses performed 14 days post‐CRC cell injection revealed that the lack of IFNα/β receptor on KCs did not inhibit the capacity of IFNα to limit tumor growth (Fig EV5B and C, and Movie EV7). The gene discussed is IFNA1; the disease is neoplasm.